Apr 09, 2020 8:30am EDT Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea
Apr 08, 2020 8:30am EDT Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial
Mar 24, 2020 8:30am EDT Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19
Mar 23, 2020 8:30am EDT Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials
Mar 13, 2020 2:56pm EDT Algernon Contacts Gates Foundation Regarding Funding for New Coronavirus Treatments
Mar 13, 2020 8:30am EDT Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use
